Home	Fast Track My Amedeo FAQ About	Flying Publisher
Fast Track	FPG #8: Alternative Treatments in Psychiatry FPG #7: Critical Care in Neurology	Free Medical Books

Prostate Cancer

Free Subscription Articles published in J Urol Retrieve available abstracts of 264 articles: HTML format Text format

Single Articles

January 2012
1. SINGH DK , Hersey K, Perlis N, Crook J, et al
   The Effect of Radiation on Semen Quality and Fertility in Men Treated With Brachytherapy for Early Stage Prostate Cancer.
   J Urol. 2012.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
2. HOLMES JA , Carpenter WR, Wu Y, Hendrix LH, et al
   Impact of Distance to a Urologist on Early Diagnosis of Prostate Cancer Among Black and White Patients.
   J Urol. 2012.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
3. NELSON JB
   Focal Therapy Will Become Standard Treatment for Localized Prostate Cancer.
   J Urol. 2012.
   PubMed     Text format     Related articles   
   
   
   
   
4. SALAGIERSKI M , Schalken JA
   Molecular Diagnosis of Prostate Cancer: PCA3 and TMPRSS2:ERG Gene Fusion.
   J Urol. 2012.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
5. MORGANS AK , Hancock ML, Barnette KG, Steiner MS, et al
   Racial Differences in Bone Mineral Density and Fractures in Men Receiving Androgen Deprivation Therapy for Prostate Cancer.
   J Urol. 2012.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
6. WALSH PC
   Re: Usefulness of Prostate-Specific Antigen (PSA) Rise as a Marker of Prostate Cancer in Men Treated With Dutasteride: Lessons From the REDUCE Study.
   J Urol. 2012;187:144-5.
   PubMed     Text format     Related articles   
   
   
   
   
7. WALSH PC
   Re: a novel two-stage, transdisciplinary study identifies digoxin as a possible drug for prostate cancer treatment.
   J Urol. 2012;187:143.
   PubMed     Text format     Related articles   
   
   
   
   
8. WALSH PC
   Re: association of clinical benign prostate hyperplasia with prostate cancer incidence and mortality revisited: a nationwide cohort study of 3,009,258 men.
   J Urol. 2012;187:142.
   PubMed     Text format     Related articles   
   
   
   
   
9. WALSH PC
   Re: smoking and prostate cancer survival and recurrence.
   J Urol. 2012;187:141-2.
   PubMed     Text format     Related articles   
   
   
   
   December 2011
10. SHIOTA M , Song Y, Takeuchi A, Yokomizo A, et al
    Antioxidant Therapy Alleviates Oxidative Stress by Androgen Deprivation and Prevents Conversion From Androgen Dependent to Castration Resistant Prostate Cancer.
    J Urol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
11. ATALA A
    Re: differential transformation capacity of SRC family kinases during the initiation of prostate cancer.
    J Urol. 2011;186:2493.
    PubMed     Text format     Related articles   
    
    
    
    
12. ATALA A
    Re: Role of Autonomous Androgen Receptor Signaling in Prostate Cancer Initiation is Dichotomous and Depends on the Oncogenic Signal.
    J Urol. 2011;186:2493-4.
    PubMed     Text format     Related articles   
    
    
    
    
13. KAPLAN SA
    Re: mortality trends for benign prostatic hyperplasia and prostate cancer in english populations 1979-2006.
    J Urol. 2011;186:2332.
    PubMed     Text format     Related articles   
    
    
    
    
14. MOREY AF
    Re: Penile Implant Utilization Following Treatment for Prostate Cancer: Analysis of the SEER-Medicare Database.
    J Urol. 2011;186:2299-300.
    PubMed     Text format     Related articles   
    
    
    
    
15. SIEGEL C
    Re: a clinically relevant approach to imaging prostate cancer: review.
    J Urol. 2011;186:2255.
    PubMed     Text format     Related articles   
    
    
    
    
16. WALSH PC
    Re: denosumab versus zoledronic Acid for treatment of bone metastases in men with castration-resistant prostate cancer: a randomised, double-blind study.
    J Urol. 2011;186:2254-5.
    PubMed     Text format     Related articles   
    
    
    
    
17. WALSH PC
    Re: abiraterone and increased survival in metastatic prostate cancer.
    J Urol. 2011;186:2253-4.
    PubMed     Text format     Related articles   
    
    
    
    
18. CALISKAN S
    Re: Small prostate size and high grade disease--biology or artifact?: J. J. Liu, J. D. Brooks, M. Ferrari, R. Nolley and J. C. Presti, Jr. J Urol 2011; 185: 2108-2111.
    J Urol. 2011;186:2504.
    PubMed     Text format     Related articles   
    
    
    
    
19. MULLER RL , Moreira DM
    Editorial comment.
    J Urol. 2011;186:2238.
    PubMed     Text format     Related articles   
    
    
    
    
20. HADASCHIK BA , Kuru TH, Tulea C, Rieker P, et al
    A novel stereotactic prostate biopsy system integrating pre-interventional magnetic resonance imaging and live ultrasound fusion.
    J Urol. 2011;186:2214-20.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
21. REESE AC , Fradet V, Whitson JM, Davis CB, et al
    Poor agreement of prostate specific antigen doubling times calculated using ultrasensitive versus standard prostate specific antigen values: important impact on risk assessment.
    J Urol. 2011;186:2228-32.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    November 2011
22. TROCK BJ
    Re: Risk of Death From Prostate Cancer After Radical Prostatectomy or Brachytherapy in Men With Low or Intermediate Risk Disease N. D. Arvold, M. H. Chen, J. W. Moul, B. J. Moran, D. E. Dosoretz, L. L. Banez, M. J. Katin, M. H. Braccioforte and A. V.
    J Urol. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
23. SHIKANOV S , Eggener SE
    Hazard of Prostate Cancer Specific Mortality After Radical Prostatectomy.
    J Urol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
24. LIU M , Wang J, Xu Y, Wei D, et al
    Risk Loci on Chromosome 8q24 are Associated With Prostate Cancer in Northern Chinese Men.
    J Urol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
25. COETZEE GA
    The Usefulness of Prostate Cancer Genome-Wide Association Studies.
    J Urol. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
26. ROGERS CL , Alder SC, Rogers RL, Hopkins SA, et al
    High Dose Brachytherapy as Monotherapy for Intermediate Risk Prostate Cancer.
    J Urol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
27. MAKAROV DV , Desai RA, Yu JB, Sharma R, et al
    The Population Level Prevalence and Correlates of Appropriate and Inappropriate Imaging to Stage Incident Prostate Cancer in the Medicare Population.
    J Urol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
28. STEWART SB , Banez LL, Robertson CN, Freedland SJ, et al
    Utilization Trends at a Multidisciplinary Prostate Cancer Clinic: Initial 5-Year Experience From the Duke Prostate Center.
    J Urol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
29. GRIEBLING TL
    Re: androgen deprivation therapy in prostate cancer: are rising concerns leading to falling use?
    J Urol. 2011;186:1881.
    PubMed     Text format     Related articles   
    
    
    
    
30. GRIEBLING TL
    Re: prostate-specific antigen velocity based risk-adapted discontinuation of prostate cancer screening in elderly men.
    J Urol. 2011;186:1880-1.
    PubMed     Text format     Related articles   
    
    
    
    
31. PENSON DF
    Re: overtreatment of men with low-risk prostate cancer and significant comorbidity.
    J Urol. 2011;186:1879-80.
    PubMed     Text format     Related articles   
    
    
    
    
32. PENSON DF
    Re: Managing Localized Prostate Cancer by Radical Prostatectomy or Watchful Waiting: Cost Analysis of a Randomized Trial (SPCG-4).
    J Urol. 2011;186:1878-9.
    PubMed     Text format     Related articles   
    
    
    
    
33. PENSON DF
    Re: do men make informed decisions about prostate cancer screening? Baseline results from the "take the wheel" trial.
    J Urol. 2011;186:1877-8.
    PubMed     Text format     Related articles   
    
    
    
    
34. PENSON DF
    Re: Patient Preferences and Urologist Recommendations Among Local-Stage Prostate Cancer Patients who Present for Initial Consultation and Second Opinions.
    J Urol. 2011;186:1877.
    PubMed     Text format     Related articles   
    
    
    
    
35. WALSH PC
    Re: radical prostatectomy versus watchful waiting in early prostate cancer.
    J Urol. 2011;186:1875.
    PubMed     Text format     Related articles   
    
    
    
    
36. WALSH PC
    Re: disease-specific survival of men with prostate cancer detected during the screening interval: results of the European randomized study of screening for prostate cancer-rotterdam after 11 years of follow-up.
    J Urol. 2011;186:1874.
    PubMed     Text format     Related articles   
    
    
    
    October 2011
37. KLOTZ L
    Re: Delay of Surgery in Men With Low Risk Prostate Cancer D. O'Brien, S. Loeb, G. F. Carvalhal, B. B. McGuire, D. Kan, M. D. Hofer, J. T. Casey, B. T. Helf and W. J. CatalonaJ Urol 2011; 185: 2143-2147.
    J Urol. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
38. MITIN T , Chen MH, Zhang Y, Moran BJ, et al
    Diabetes Mellitus, Race and the Odds of High Grade Prostate Cancer in Men Treated With Radiation Therapy.
    J Urol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
39. LU PH , Yu CC, Chiang PC, Chen YC, et al
    Paclitaxel Induces Apoptosis Through Activation of Nuclear Protein Kinase C-delta and Subsequent Activation of Golgi Associated Cdk1 in Human Hormone Refractory Prostate Cancer.
    J Urol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
40. SMITH MR , Malkowicz SB, Brawer MK, Hancock ML, et al
    Toremifene Decreases Vertebral Fractures in Men Younger Than 80 Years Receiving Androgen Deprivation Therapy for Prostate Cancer.
    J Urol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
41. DAVIES JD , Aghazadeh MA, Phillips S, Salem S, et al
    Prostate Size as a Predictor of Gleason Score Upgrading in Patients With Low Risk Prostate Cancer.
    J Urol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
42. FRIEDMAN AE
    Re: testosterone therapy in men with untreated prostate cancer a. Morgentaler, L. I. Lipshultz, R. Bennett, m. Sweeney, d. Avila, jr. And m. Khera j urol 2011; 185: 1256-1261.
    J Urol. 2011;186:1559-60.
    PubMed     Text format     Related articles   
    
    
    
    
43. WALSH PC
    Urological oncology: prostate cancer.
    J Urol. 2011;186:1308-10.
    PubMed     Text format     Related articles   
    
    
    
    
44. MOUSSA AS
    Editorial comment.
    J Urol. 2011;186:1290.
    PubMed     Text format     Related articles   
    
    
    
    
45. PINTO PA , Chung PH, Rastinehad AR, Baccala AA Jr, et al
    Magnetic resonance imaging/ultrasound fusion guided prostate biopsy improves cancer detection following transrectal ultrasound biopsy and correlates with multiparametric magnetic resonance imaging.
    J Urol. 2011;186:1281-5.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    September 2011
46. CATALONA WJ
    Re: Prospective Evaluation of Operating Characteristics of Prostate Cancer Detection Biomarkers Y. Liang, D. P. Ankerst, N. S. Ketchum, B. Ercole, G. Shah, J. D. Shaughnessy, Jr., R. J. Leach and I. M. ThompsonJ Urol 2011; 185: 104-110.
    J Urol. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
47. LASKIEWICZ L , Jiang Z, Altieri DC, Languino LR, et al
    The Search for a Better Prostate Cancer Biomarker.
    J Urol. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
48. WU J , Gonzalgo ML
    Use of Magnetic Resonance Imaging to Accurately Detect and Stage Prostate Cancer: The Hype and the Hope.
    J Urol. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
49. SHARIAT SF , Chromecki TF, Hoefer J, Barbieri CE, et al
    Soluble gp130 Regulates Prostate Cancer Invasion and Progression in an Interleukin-6 Dependent and Independent Manner.
    J Urol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
50. BADEN J , Adams S, Astacio T, Jones J, et al
    Predicting Prostate Biopsy Result in Men With Prostate Specific Antigen 2.0 to 10.0 ng/ml Using an Investigational Prostate Cancer Methylation Assay.
    J Urol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
51. O'BRIEN BA , Cohen RJ, Ryan A, Sengupta S, et al
    A New Preoperative Nomogram to Predict Minimal Prostate Cancer: Accuracy and Error Rates Compared to Other Tools to Select Patients for Active Surveillance.
    J Urol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
52. KASPERZYK JL , Shappley WV 3rd, Kenfield SA, Mucci LA, et al
    Watchful Waiting and Quality of Life Among Prostate Cancer Survivors in the Physicians' Health Study.
    J Urol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
53. DASKIVICH TJ , Chamie K, Kwan L, Labo J, et al
    Improved Prediction of Long-Term, Other Cause Mortality in Men With Prostate Cancer.
    J Urol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
54. HECKMAN JE , Chamie K, Maliski SL, Fink A, et al
    The Role of Self-Efficacy in Quality of Life for Disadvantaged Men With Prostate Cancer.
    J Urol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
55. PORTEN SP , Whitson JM, Cowan JE, Perez N, et al
    Changes in Cancer Volume in Serial Biopsies of Men on Active Surveillance for Early Stage Prostate Cancer.
    J Urol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
56. WALSH PC
    Urological oncology: prostate cancer.
    J Urol. 2011;186:903-5.
    PubMed     Text format     Related articles   
    
    
    
    
57. AGARWAL N
    Editorial comment.
    J Urol. 2011;186:887.
    PubMed     Text format     Related articles   
    
    
    
    
58. WOMBLE PR , VanVeldhuizen PJ, Nisbet AA, Reed GA, et al
    A phase II clinical trial of neoadjuvant ketoconazole and docetaxel chemotherapy before radical prostatectomy in high risk patients.
    J Urol. 2011;186:882-7.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
59. EPSTEIN JI
    Prognostic significance of tumor volume in radical prostatectomy and needle biopsy specimens.
    J Urol. 2011;186:790-7.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
60. SHAH SK , Fleet TM, Williams V, Smith AY, et al
    SEER coding standards result in underestimation of positive surgical margin incidence at radical prostatectomy: results of a systematic audit.
    J Urol. 2011;186:855-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    August 2011
61. AMIN A , Partin A, Epstein JI
    Gleason Score 7 Prostate Cancer on Needle Biopsy: Relation of Primary Pattern 3 or 4 to Pathological Stage and Progression After Radical Prostatectomy.
    J Urol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
62. BOTTO H , Neuzillet Y, Lebret T, Camparo P, et al
    High Incidence of Predominant Gleason Pattern 4 Localized Prostate Cancer is Associated With Low Serum Testosterone.
    J Urol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
63. GALVAO DA , Taaffe DR, Spry N, Joseph D, et al
    Acute Versus Chronic Exposure to Androgen Suppression for Prostate Cancer: Impact on the Exercise Response.
    J Urol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
64. CHOI S
    The Role of Magnetic Resonance Imaging in the Detection of Prostate Cancer.
    J Urol. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
65. WALSH PC
    Urological oncology: prostate cancer.
    J Urol. 2011;186:530-2.
    PubMed     Text format     Related articles   
    
    
    
    
66. DERWEESH IH
    Editorial comment.
    J Urol. 2011;186:480-1.
    PubMed     Text format     Related articles   
    
    
    
    
67. GAYLIS FD , Sass M
    Re: Annual surgical caseload and open radical prostatectomy outcomes: improving temporal trends. L. Budaus, F. Abdollah, M. Sun, M. Morgan, R. Johal, R. Thuret, K. C. Zorn, H. Isbarn, S. F. Shariat, F. Montorsi, P. Perrotte, M. Graefen and P. I. Karak
    J Urol. 2011;186:757-8.
    PubMed     Text format     Related articles   
    
    
    
    
68. PATEL VR , Coelho RF, Rocco B, Orvieto M, et al
    Positive surgical margins after robotic assisted radical prostatectomy: a multi-institutional study.
    J Urol. 2011;186:511-6.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
69. ABAZA R
    Editorial comment.
    J Urol. 2011;186:516-7.
    PubMed     Text format     Related articles   
    
    
    
    
70. LOEB S , Feng Z, Ross A, Trock BJ, et al
    Can we stop prostate specific antigen testing 10 years after radical prostatectomy?
    J Urol. 2011;186:500-5.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
71. KEEGAN K
    Editorial comment.
    J Urol. 2011;186:492-3.
    PubMed     Text format     Related articles   
    
    
    
    
72. AL-HUSSAIN T , Carter HB, Epstein JI
    Significance of prostate adenocarcinoma perineural invasion on biopsy in patients who are otherwise candidates for active surveillance.
    J Urol. 2011;186:470-3.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
73. MARONI P , Crawford ED
    Assessment of men before androgen deprivation therapy.
    J Urol. 2011;186:371-2.
    PubMed     Text format     Related articles   
    
    
    
    
74. LAVERY HJ , Prall DN, Abaza R
    Active patient decision making regarding nerve sparing during radical prostatectomy: a novel approach.
    J Urol. 2011;186:487-92.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
75. NIELSEN M
    Editorial comment.
    J Urol. 2011;186:493.
    PubMed     Text format     Related articles   
    
    
    
    
76. JONES JS
    Editorial comment.
    J Urol. 2011;186:464.
    PubMed     Text format     Related articles   
    
    
    
    July 2011
77. KAPOOR DA , Zimberg SH, Ohrin LM, Underwood W 3rd, et al
    Utilization Trends in Prostate Cancer Therapy.
    J Urol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
78. HALL SJ , Klotz L, Pantuck AJ, George DJ, et al
    Integrated Safety Data From 4 Randomized, Double-Blind, Controlled Trials of Autologous Cellular Immunotherapy With Sipuleucel-T in Patients With Prostate Cancer.
    J Urol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
79. ZAYTOUN OM , Moussa AS, Gao T, Fareed K, et al
    Office Based Transrectal Saturation Biopsy Improves Prostate Cancer Detection Compared to Extended Biopsy in the Repeat Biopsy Population.
    J Urol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
80. D'AMICO AV , Chen MH, Dosoretz D, Katin M, et al
    Coronary Artery Revascularization and the Risk of Death in Men With Prostate Cancer.
    J Urol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
81. MILLER DC , Murtagh DS, Suh RS, Knapp PM, et al
    Regional Collaboration to Improve Radiographic Staging Practices Among Men With Early Stage Prostate Cancer.
    J Urol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
82. CHANG P , Szymanski KM, Dunn RL, Chipman JJ, et al
    Expanded Prostate Cancer Index Composite for Clinical Practice: Development and Validation of a Practical Health Related Quality of Life Instrument for Use in the Routine Clinical Care of Patients With Prostate Cancer.
    J Urol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
83. BORIN JF
    Imaging for Staging Prostate Cancer: Too Much or Not Enough?
    J Urol. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
84. CRAWFORD ED , Tombal B, Miller K, Boccon-Gibod L, et al
    A Phase III Extension Trial With a 1-Arm Crossover From Leuprolide to Degarelix: Comparison of Gonadotropin-Releasing Hormone Agonist and Antagonist Effect on Prostate Cancer.
    J Urol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
85. MOORE CM , Klotz L, Emberton M
    Re: A Critical Analysis of the Tumor Volume Threshold for Clinically Insignificant Prostate Cancer Using a Data Set of a Randomized Screening Trial T. Wolters, M. J. Roobol, P. J. van Leeuwen, R. C. van den Bergh, R. F. Hoedemaeker, G. J. van Leenders
    J Urol. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
86. DICKINSON L , Ahmed HU, Emberton M
    Re: Salvage Radical Prostatectomy Following Primary High Intensity Focused Ultrasound for Treatment of Prostate Cancer N. Lawrentschuk, A. Finelli, T. H. van der Kwast, P. Ryan, D. M. Bolton, N. E. Fleshner, J. Trachtenberg, L. Klotz, M. Robinette and
    J Urol. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
87. YUAN H , Wei X, Zhang G, Li C, et al
    B7-H3 Over Expression in Prostate Cancer Promotes Tumor Cell Progression.
    J Urol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
88. WALSH PC
    Urological oncology: prostate cancer.
    J Urol. 2011;186:103-6.
    PubMed     Text format     Related articles   
    
    
    
    
89. CIMEN HI , Altinova S, Balbay MD
    Comparative effectiveness of perineal versus retropubic and minimally invasive radical prostatectomy.
    J Urol. 2011;186:351.
    PubMed     Text format     Related articles   
    
    
    
    
90. HERTEL JD , Humphrey PA
    Ductal adenocarcinoma of the prostate.
    J Urol. 2011;186:277-8.
    PubMed     Text format     Related articles   
    
    
    
    
91. BLITZ BF , Schwartz BN
    Re: comparative effectiveness of perineal versus retropubic and minimally invasive radical prostatectomy. S. M. Prasad, X. Gu, R. Lavelle, S. R. Lipsitz and J. C. Hu J Urol 2011; 185: 111-115.
    J Urol. 2011;186:350-1.
    PubMed     Text format     Related articles   
    
    
    
    June 2011
92. MISTRY R , Hughes D, Wadhwa V, Parr N, et al
    Lateral Spine Radiographs Before Androgen Deprivation Treatment Detect a High Incidence of Undiagnosed Vertebral Fragility Fractures in Men With Advanced Prostate Cancer.
    J Urol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
93. ZHANG M
    Re: Expression of Estrogen Related Proteins in Hormone Refractory Prostate Cancer: Association With Tumor Progression O. Celhay, M. Yacoub, J. Irani, B. Dore, O. Cussenot and G. FromontJ Urol 2010; 184: 2172-2178.
    J Urol. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
94. AHMAD S , Casey G, Cronin M, Rajendran S, et al
    Induction of Effective Antitumor Response After Mucosal Bacterial Vector Mediated DNA Vaccination With Endogenous Prostate Cancer Specific Antigen.
    J Urol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
95. MCKENNEY JK , Simko J, Bonham M, True LD, et al
    The Potential Impact of Reproducibility of Gleason Grading in Men With Early Stage Prostate Cancer Managed by Active Surveillance: A Multi-Institutional Study.
    J Urol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
96. MASTERSON TA , Cheng L, Mehan RM, Koch MO, et al
    Tumor Focality Does Not Predict Biochemical Recurrence After Radical Prostatectomy in Men With Clinically Localized Prostate Cancer.
    J Urol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
97. AHMED HU , Hu Y, Carter T, Arumainayagam N, et al
    Characterizing Clinically Significant Prostate Cancer Using Template Prostate Mapping Biopsy.
    J Urol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
98. SAYLOR PJ , Morton RA, Hancock ML, Barnette KG, et al
    Factors Associated With Vertebral Fractures in Men Treated With Androgen Deprivation Therapy for Prostate Cancer.
    J Urol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
99. WALSH PC
    Urological oncology: prostate cancer.
    J Urol. 2011;185:2153-7.
    PubMed     Text format     Related articles   
    
    
    
    
100. DE LA TAILLE A , Irani J, Graefen M, Chun F, et al
     Clinical evaluation of the PCA3 assay in guiding initial biopsy decisions.
     J Urol. 2011;185:2119-25.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
101. LIU JJ , Brooks JD, Ferrari M, Nolley R, et al
     Small prostate size and high grade disease--biology or artifact?
     J Urol. 2011;185:2108-11.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
102. RODRIGUEZ-COVARRUBIAS F , Gonzalez-Ramirez A, Aguilar-Davidov B, Castillejos-Molina R, et al
     Extended sampling at first biopsy improves cancer detection rate: results of a prospective, randomized trial comparing 12 versus 18-core prostate biopsy.
     J Urol. 2011;185:2132-6.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
103. SANDHU JS , Gotto GT, Herran LA, Scardino PT, et al
     Age, obesity, medical comorbidities and surgical technique are predictive of symptomatic anastomotic strictures after contemporary radical prostatectomy.
     J Urol. 2011;185:2148-52.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     May 2011
104. SANDERS AJ , Martin TA, Ye L, Mason MD, et al
     EPLIN is a Negative Regulator of Prostate Cancer Growth and Invasion.
     J Urol. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
105. TAN N , Klein EA, Li J, Moussa AS, et al
     Statin Use and Risk of Prostate Cancer in a Population of Men Who Underwent Biopsy.
     J Urol. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
106. ARVOLD ND , Chen MH, Moul JW, Moran BJ, et al
     Risk of Death From Prostate Cancer After Radical Prostatectomy or Brachytherapy in Men With Low or Intermediate Risk Disease.
     J Urol. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
107. BARQAWI AB , Rove KO, Gholizadeh S, O'Donnell CI, et al
     The Role of 3-Dimensional Mapping Biopsy in Decision Making for Treatment of Apparent Early Stage Prostate Cancer.
     J Urol. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
108. HAN M , Tewari AK, Lee BR
     Pelvic lymph node dissection during laparoscopic/robotic prostatectomy.
     J Urol. 2011;185:1667.
     PubMed     Text format     Related articles   
     
     
     
     
109. FUJITA K , Hosomi M, Tanigawa G, Okumi M, et al
     Prostatic inflammation detected in initial biopsy specimens and urinary pyuria are predictors of negative repeat prostate biopsy.
     J Urol. 2011;185:1722-7.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
110. TOLLEFSON MK , Gettman MT, Karnes RJ, Frank I, et al
     Administrative data sets are inaccurate for assessing functional outcomes after radical prostatectomy.
     J Urol. 2011;185:1686-90.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
111. PORPIGLIA F , Fiori C, Cavallone B, Morra I, et al
     Extraperitoneoscopic transcapsular adenomectomy: complications and functional results after at least 1 year of followup.
     J Urol. 2011;185:1668-73.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
112. TREIYER A , Anheuser P, Butow Z, Steffens J, et al
     A single center prospective study: prediction of postoperative general quality of life, potency and continence after radical retropubic prostatectomy.
     J Urol. 2011;185:1681-5.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
113. PIERORAZIO PM , Ross AE, Schaeffer EM, Epstein JI, et al
     A contemporary analysis of outcomes of adenocarcinoma of the prostate with seminal vesicle invasion (pT3b) after radical prostatectomy.
     J Urol. 2011;185:1691-7.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
114. SECIN FP
     Editorial comment.
     J Urol. 2011;185:1666.
     PubMed     Text format     Related articles   
     
     
     
     
115. EIFLER JB , Levinson AW, Hyndman ME, Trock BJ, et al
     Pelvic lymph node dissection is associated with symptomatic venous thromboembolism risk during laparoscopic radical prostatectomy.
     J Urol. 2011;185:1661-5.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
116. ATALA A
     Re: A Novel Imaging Approach for Early Detection of Prostate Cancer Based on Endogenous Zinc Sensing.
     J Urol. 2011;185:1976.
     PubMed     Text format     Related articles   
     
     
     
     
117. WALSH PC
     Re: Interval Cancers in the Antwerp European Randomised Study of Screening for Prostate Cancer Study, Using a 6 Year Screening Interval.
     J Urol. 2011;185:1707.
     PubMed     Text format     Related articles   
     
     
     
     
118. WALSH PC
     Re: Suicide Risk in Men With Prostate-Specific Antigen-Detected Early Prostate Cancer: A Nationwide Population-Based Cohort Study From PCBaSe Sweden.
     J Urol. 2011;185:1706-1707.
     PubMed     Text format     Related articles   
     
     
     
     
119. WALSH PC
     Re: Prostate Specific Antigen Concentration at Age 60 and Death or Metastasis From Prostate Cancer: Case-Control Study.
     J Urol. 2011;185:1705.
     PubMed     Text format     Related articles   
     
     
     
     April 2011
120. LANGLEY RE , Cafferty FH, Pollock PA, Price P, et al
     Re: Toremifene to Reduce Fracture Risk in Men Receiving Androgen Deprivation Therapy for Prostate Cancer M. R. Smith, R. A. Morton, K. G. Barnette, P. R. Sieber, S. B. Malkowicz, D. Rodriguez, M. L. Hancock and M. S. SteinerJ Urol 2010; 184: 1316-1321
     J Urol. 2011.
     PubMed     Text format     Related articles   
     
     
     
     
121. KOSAKA T , Miyajima A, Shirotake S, Suzuki E, et al
     Long-Term Androgen Ablation and Docetaxel Up-Regulate Phosphorylated Akt in Castration Resistant Prostate Cancer.
     J Urol. 2011.
     PubMed     Text format     Related articles   
     
     
     
     
122. JOUNG JY , Lee YS, Park S, Yoon H, et al
     Haplotype Analysis of Prostate Stem Cell Antigen and Association With Prostate Cancer Risk.
     J Urol. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
123. MORELLI G , Pagni R, Mariani C, Minervini R, et al
     Results of Vardenafil Mediated Power Doppler Ultrasound, Contrast Enhanced Ultrasound and Systematic Random Biopsies to Detect Prostate Cancer.
     J Urol. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
124. BAROCAS DA , Motley S, Cookson MS, Chang SS, et al
     Oxidative Stress Measured by Urine F2-Isoprostane Level is Associated With Prostate Cancer.
     J Urol. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
125. O'BRIEN D , Loeb S, Carvalhal GF, McGuire BB, et al
     Delay of Surgery in Men With Low Risk Prostate Cancer.
     J Urol. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
126. DEL JUNCO DJ , Fox EE, Cooper S, Goldhagen M, et al
     Increasing Low Risk Prostate Cancer Incidence in United States Air Force Servicemen and Selection of Treatments.
     J Urol. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
127. MINER MM
     Editorial comment.
     J Urol. 2011;185:1261.
     PubMed     Text format     Related articles   
     
     
     
     
128. AGARWAL PK
     Editorial comment.
     J Urol. 2011;185:1261.
     PubMed     Text format     Related articles   
     
     
     
     
129. CHAMIE K , Sadetsky N, Litwin MS
     Physician assessment of pretreatment functional status: a process-outcomes link.
     J Urol. 2011;185:1229-33.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
130. SUTHERLAND DE , Linder B, Guzman AM, Hong M, et al
     Posterior rhabdosphincter reconstruction during robotic assisted radical prostatectomy: results from a phase II randomized clinical trial.
     J Urol. 2011;185:1262-7.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
131. EGGENER S
     Editorial comment.
     J Urol. 2011;185:1254-5.
     PubMed     Text format     Related articles   
     
     
     
     
132. ATALA A
     Re: eIF4E Phosphorylation Promotes Tumorigenesis and is Associated With Prostate Cancer Progression.
     J Urol. 2011;185:1533.
     PubMed     Text format     Related articles   
     
     
     
     
133. GRIEBLING TL
     Re: the use of zoledronic Acid in men receiving androgen deprivation therapy for prostate cancer with severe osteopenia or osteoporosis.
     J Urol. 2011;185:1279.
     PubMed     Text format     Related articles   
     
     
     
     
134. WALSH PC
     Re: effect of dutasteride on prostate biopsy rates and the diagnosis of prostate cancer in men with lower urinary tract symptoms and enlarged prostates in the combination of avodart and tamsulosin trial.
     J Urol. 2011;185:1276-7.
     PubMed     Text format     Related articles   
     
     
     
     
135. WALSH PC
     Re: FDA panel votes against drugs said to prevent prostate cancer.
     J Urol. 2011;185:1275-6.
     PubMed     Text format     Related articles   
     
     
     
     
136. WALSH PC
     Re: comorbidity and mortality results from a randomized prostate cancer screening trial.
     J Urol. 2011;185:1274-5.
     PubMed     Text format     Related articles   
     
     
     
     March 2011
137. PARKER AS
     Re: Quality of Life After Open or Robotic Prostatectomy, Cryoablation or Brachytherapy for Localized Prostate Cancer J. B. Malcolm, M. D. Fabrizio, B. B. Barone, R. W. Given, R. S. Lance, D. F. Lynch, J. W. Davis, M. E. Shaves and P. F. SchellhammerJ
     J Urol. 2011.
     PubMed     Text format     Related articles   
     
     
     
     
138. NEULANDER EZ
     Re: Prostate Cancer Screening in Men 75 Years Old or Older: An Assessment of Self-Reported Health Status and Life Expectancy K. E. Hoffman, P. L. Nguyen, A. K. Ng and A. V. D'AmicoJ Urol 2010; 183: 1798-1802.
     J Urol. 2011.
     PubMed     Text format     Related articles   
     
     
     
     
139. HSU JL , Pan SL, Ho YF, Hwang TL, et al
     Costunolide Induces Apoptosis Through Nuclear Calcium(2+) Overload and DNA Damage Response in Human Prostate Cancer.
     J Urol. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
140. MEEKS JJ , Brandes SB, Morey AF, Thom M, et al
     Urethroplasty for Radiotherapy Induced Bulbomembranous Strictures: A Multi-Institutional Experience.
     J Urol. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
141. GRANT JD , Litwin MS, Kwan L, Lee SP, et al
     Does Hormone Therapy Exacerbate the Adverse Effects of Radiotherapy in Men With Prostate Cancer? A Quality of Life Study.
     J Urol. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
142. CHOI WW , Williams SB, Gu X, Lipsitz SR, et al
     Overuse of Imaging for Staging Low Risk Prostate Cancer.
     J Urol. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
143. CATALONA WJ , Partin AW, Sanda MG, Wei JT, et al
     A Multicenter Study of [-2]Pro-Prostate Specific Antigen Combined With Prostate Specific Antigen and Free Prostate Specific Antigen for Prostate Cancer Detection in the 2.0 to 10.0 ng/ml Prostate Specific Antigen Range.
     J Urol. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
144. WHITSON JM , Porten SP, Hilton JF, Cowan JE, et al
     The Relationship Between Prostate Specific Antigen Change and Biopsy Progression in Patients With Prostate Cancer on Active Surveillance.
     J Urol. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
145. LOEB S
     Editorial comment.
     J Urol. 2011;185:826-7.
     PubMed     Text format     Related articles   
     
     
     
     
146. SCHELLHAMMER PF
     Editorial comment.
     J Urol. 2011;185:854.
     PubMed     Text format     Related articles   
     
     
     
     
147. ALIBHAI SM
     Editorial comment.
     J Urol. 2011;185:839-40.
     PubMed     Text format     Related articles   
     
     
     
     
148. FUTTERER JJ
     Editorial comment.
     J Urol. 2011;185:820.
     PubMed     Text format     Related articles   
     
     
     
     
149. MURPHY DG
     Editorial comment.
     J Urol. 2011;185:868.
     PubMed     Text format     Related articles   
     
     
     
     
150. FROEHNER M
     Editorial comment.
     J Urol. 2011;185:839.
     PubMed     Text format     Related articles   
     
     
     
     
151. WALSH PC
     Urological oncology: prostate cancer.
     J Urol. 2011;185:895-8.
     PubMed     Text format     Related articles   
     
     
     
     February 2011
152. CALISKAN S
     Re: Smaller Prostate Size Predicts High Grade Prostate Cancer at Final Pathology M. R. Newton, S. Phillips, S. S. Chang, P. E. Clark, M. S. Cookson, R. Davis, J. H. Fowke, S. D. Herrell, R. Baumgartner, R. Chan, V. Mishra, J. D. Blume, J. A. Smith, Jr
     J Urol. 2011.
     PubMed     Text format     Related articles   
     
     
     
     
153. SCHWARTZ GG
     Approaches to Optimizing Vitamin D Therapy in Prostate Cancer.
     J Urol. 2011.
     PubMed     Text format     Related articles   
     
     
     
     
154. KOIKE H , Morikawa Y, Sekine Y, Matsui H, et al
     Survivin Is Associated With Cell Proliferation and Has a Role in 1a,25-Dihydroxyvitamin D(3) Induced Cell Growth Inhibition in Prostate Cancer.
     J Urol. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
155. SHAIDA N , Chan P, Turley H, Jones CM, et al
     Nuclear Localization of Factor Inhibitor Hypoxia-Inducible Factor in Prostate Cancer Is Associated With Poor Prognosis.
     J Urol. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
156. WU GJ , Wu MW, Wang C, Liu Y, et al
     Enforced Expression of METCAM/MUC18 Increases Tumorigenesis of Human Prostate Cancer LNCaP Cells in Nude Mice.
     J Urol. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
157. LIN JF , Lin YC, Lin YH, Tsai TF, et al
     Zoledronic Acid Induces Autophagic Cell Death in Human Prostate Cancer Cells.
     J Urol. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
158. MORGENTALER A , Lipshultz LI, Bennett R, Sweeney M, et al
     Testosterone Therapy in Men With Untreated Prostate Cancer.
     J Urol. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
159. MERRIMEN JL , Jones G, Hussein SA, Leung CS, et al
     A Model to Predict Prostate Cancer After Atypical Findings in Initial Prostate Needle Biopsy.
     J Urol. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
160. VLAEMINCK-GUILLEM V , Devonec M, Colombel M, Rodriguez-Lafrasse C, et al
     Urinary PCA3 Score Predicts Prostate Cancer Multifocality.
     J Urol. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
161. MONDUL AM , Han M, Humphreys EB, Meinhold CL, et al
     Association of Statin Use With Pathological Tumor Characteristics and Prostate Cancer Recurrence After Surgery.
     J Urol. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
162. AHMED HU , Freeman A, Kirkham A, Sahu M, et al
     Focal Therapy for Localized Prostate Cancer: A Phase I/II Trial.
     J Urol. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
163. ANGER J
     Management of recalcitrant bladder neck contracture after radical prostatectomy for prostate cancer. UroLume stent.
     J Urol. 2011;185:391-2.
     PubMed     Text format     Related articles   
     
     
     
     
164. STONE NN , Stone MM, Rosenstein BS, Unger P, et al
     Influence of pretreatment and treatment factors on intermediate to long-term outcome after prostate brachytherapy.
     J Urol. 2011;185:495-500.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
165. EYRE SJ
     Editorial comment.
     J Urol. 2011;185:488.
     PubMed     Text format     Related articles   
     
     
     
     
166. KAPLAN SA
     Re: Antibacterial Therapy Improves the Effectiveness of Prostate Cancer Detection Using Prostate-Specific Antigen in Patients With Asymptomatic Prostatitis.
     J Urol. 2011;185:603.
     PubMed     Text format     Related articles   
     
     
     
     
167. GRIEBLING TL
     Re: Management of Prostate Cancer in Older Men: Recommendations of a Working Group of the International Society of Geriatric Oncology.
     J Urol. 2011;185:520.
     PubMed     Text format     Related articles   
     
     
     
     
168. WALSH PC
     Re: Breast and Prostate Cancer: Familial Associations.
     J Urol. 2011;185:515.
     PubMed     Text format     Related articles   
     
     
     
     January 2011
169. CALISKAN S , Kaya C
     Re: Location, Extent and Number of Positive Surgical Margins do Not Improve Accuracy of Predicting Prostate Cancer Recurrence After Radical Prostatectomy A. J. Stephenson, D. P. Wood, M. W. Kattan, E. A. Klein, P. T. Scardino, J. A. Eastham and B. S.
     J Urol. 2011.
     PubMed     Text format     Related articles   
     
     
     
     
170. JERECZEK-FOSSA BA , Zanetti IB, Zerini D, Orecchia R, et al
     Re: (11C)Choline Positron Emission Tomography/Computerized Tomography to Restage Prostate Cancer Cases With Biochemical Failure After Radical Prostatectomy and No Disease Evidence on Conventional Imaging G. Giovacchini, M. Picchio, A. Briganti, C. Coz
     J Urol. 2011.
     PubMed     Text format     Related articles   
     
     
     
     
171. LEITE KR , Tomiyama A, Reis ST, Sousa-Canavez JM, et al
     MicroRNA-100 Expression is Independently Related to Biochemical Recurrence of Prostate Cancer.
     J Urol. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
172. REED SD , Scales CD Jr, Stewart SB, Sun J, et al
     Effects of Family History and Genetic Polymorphism on the Cost-Effectiveness of Chemoprevention With Finasteride for Prostate Cancer.
     J Urol. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
173. SHTEYNSHLYUGER A , Andriole GL
     Cost-Effectiveness of Prostate Specific Antigen Screening in the United States: Extrapolating from the European Study of Screening for Prostate Cancer.
     J Urol. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
174. LAWRENTSCHUK N , Fernandes K, Bell D, Barkin J, et al
     Efficacy of a Second Line Luteinizing Hormone-Releasing Hormone Agonist After Advanced Prostate Cancer Biochemical Recurrence.
     J Urol. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
175. MOLINA A , Belldegrun A
     Novel Therapeutic Strategies for Castration Resistant Prostate Cancer: Inhibition of Persistent Androgen Production and Androgen Receptor Mediated Signaling.
     J Urol. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
176. MOHLER JL , Pantuck AJ
     Use of Abiraterone for Prostate Cancer.
     J Urol. 2011.
     PubMed     Text format     Related articles   
     
     
     
     
177. EGGENER SE , Scardino PT, Walsh PC, Han M, et al
     Predicting 15-Year Prostate Cancer Specific Mortality After Radical Prostatectomy.
     J Urol. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
178. RASTINEHAD AR , Baccala AA Jr, Chung PH, Proano JM, et al
     D'Amico Risk Stratification Correlates With Degree of Suspicion of Prostate Cancer on Multiparametric Magnetic Resonance Imaging.
     J Urol. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
179. LAWRENTSCHUK N , Finelli A, Van der Kwast TH, Ryan P, et al
     Salvage Radical Prostatectomy Following Primary High Intensity Focused Ultrasound for Treatment of Prostate Cancer.
     J Urol. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
180. BERGLUND A , Garmo H, Tishelman C, Holmberg L, et al
     Comorbidity, Treatment and Mortality: A Population Based Cohort Study of Prostate Cancer in PCBaSe Sweden.
     J Urol. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
181. BENECCHI L , Pieri AM, Pastizzaro CD, Potenzoni M, et al
     Evaluation of Prostate Specific Antigen Acceleration for Prostate Cancer Diagnosis.
     J Urol. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
182. CAI T , Nesi G, Malossini G, Bartoletti R, et al
     Re: Predicting biochemical recurrence-free survival for patients with positive pelvic lymph nodes at radical prostatectomy: C. Von Bodman, G. Godoy, D. C. Chade, A. Cronin, L. J. Tafe, S. W. Fine, V. Laudone, P. T. Scardino and J. A. Eastham J Urol 20
     J Urol. 2011;185:360-1.
     PubMed     Text format     Related articles   
     
     
     
     
183. VOLLMER RT
     Editorial comment.
     J Urol. 2011;185:125.
     PubMed     Text format     Related articles   
     
     
     
     
184. PRASAD SM , Gu X, Lavelle R, Lipsitz SR, et al
     Comparative effectiveness of perineal versus retropubic and minimally invasive radical prostatectomy.
     J Urol. 2011;185:111-5.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
185. HOFFMAN KE , Nguyen PL, Chen MH, Chen RC, et al
     Recommendations for post-prostatectomy radiation therapy in the United States before and after the presentation of randomized trials.
     J Urol. 2011;185:116-20.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
186. WALSH PC
     Re: comparative risk-adjusted mortality outcomes after primary surgery, radiotherapy, or androgen-deprivation therapy for localized prostate cancer.
     J Urol. 2011;185:141.
     PubMed     Text format     Related articles   
     
     
     
     
187. WALSH PC
     Re: years of potential life lost caused by prostate cancer deaths in the United States-projection from 2004 through 2050.
     J Urol. 2011;185:141-2.
     PubMed     Text format     Related articles   
     
     
     
     
188. WALSH PC
     Re: the relationship between prostate-specific antigen and prostate cancer risk: the prostate biopsy collaborative group.
     J Urol. 2011;185:140.
     PubMed     Text format     Related articles   
     
     
     
     
189. WALSH PC
     Re: Risk Profiles and Treatment Patterns Among Men Diagnosed as Having Prostate Cancer and a Prostate-Specific Antigen Level Below 4.0 ng/ml.
     J Urol. 2011;185:139.
     PubMed     Text format     Related articles   
     
     
     
     December 2010
190. JENTZMIK F , Stephan C, Lein M, Miller K, et al
     Sarcosine in Prostate Cancer Tissue is Not a Differential Metabolite for Prostate Cancer Aggressiveness and Biochemical Progression.
     J Urol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
191. WAGNER C , Luka Z
     Sarcosine, Folate Metabolism and Prostate Cancer-Is There a Link?
     J Urol. 2010.
     PubMed     Text format     Related articles   
     
     
     
     
192. BREYER BN , McAninch JW
     Management of Recalcitrant Bladder Neck Contracture After Radical Prostatectomy for Prostate Cancer.
     J Urol. 2010.
     PubMed     Text format     Related articles   
     
     
     
     
193. FALZARANO SM , Zhou M, Hernandez AV, Klein EA, et al
     Single Focus Prostate Cancer: Pathological Features and ERG Fusion Status.
     J Urol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
194. ADAMY A , Yee DS, Matsushita K, Maschino A, et al
     Role of Prostate Specific Antigen and Immediate Confirmatory Biopsy in Predicting Progression During Active Surveillance for Low Risk Prostate Cancer.
     J Urol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
195. FRANCISCO IF , Werner L, Regan MM, Garnick MB, et al
     Risk Stratification and Validation of Prostate Specific Antigen Density as Independent Predictor of Progression in Men With Low Risk Prostate Cancer During Active Surveillance.
     J Urol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
196. NGO TC , Turnbull BB, Lavori PW, Presti JC Jr, et al
     The Prostate Cancer Risk Calculator From the Prostate Cancer Prevention Trial Underestimates the Risk of High Grade Cancer in Contemporary Referral Patients.
     J Urol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
197. MILLER DC , Murtagh DS, Suh RS, Knapp PM, et al
     Establishment of a urological surgery quality collaborative.
     J Urol. 2010;184:2485-90.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
198. GONZALEZ C
     Editorial comment.
     J Urol. 2010;184:2490.
     PubMed     Text format     Related articles   
     
     
     
     
199. ZAKIAN KL , Hricak H, Ishill N, Reuter VE, et al
     An exploratory study of endorectal magnetic resonance imaging and spectroscopy of the prostate as preoperative predictive biomarkers of biochemical relapse after radical prostatectomy.
     J Urol. 2010;184:2320-7.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
200. MORGAN TM , Welty CJ, Vakar-Lopez F, Lin DW, et al
     Ductal adenocarcinoma of the prostate: increased mortality risk and decreased serum prostate specific antigen.
     J Urol. 2010;184:2303-7.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
201. SECIN FP , Savage C, Abbou C, de La Taille A, et al
     The learning curve for laparoscopic radical prostatectomy: an international multicenter study.
     J Urol. 2010;184:2291-6.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
202. YE H , Walsh PC, Epstein JI
     Skeletal muscle involvement by limited Gleason score 6 adenocarcinoma of the prostate on needle biopsy is not associated with adverse findings at radical prostatectomy.
     J Urol. 2010;184:2308-12.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
203. BUDAUS L , Abdollah F, Sun M, Morgan M, et al
     Annual surgical caseload and open radical prostatectomy outcomes: improving temporal trends.
     J Urol. 2010;184:2285-90.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     November 2010
204. QIAO Y , Wang L, Cai LQ, Tan C, et al
     Inhibition of Aberrant Androgen Receptor Induction of Prostate Specific Antigen Gene Expression, Cell Proliferation and Tumor Growth by 17alpha-Estradiol in Prostate Cancer.
     J Urol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
205. ERICKSON BA , McAninch JW, Eisenberg ML, Washington SL, et al
     Management for Prostate Cancer Treatment Related Posterior Urethral and Bladder Neck Stenosis With Stents.
     J Urol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
206. WIBOWO E , Schellhammer P, Wassersug RJ
     Role of Estrogen in Normal Male Function: Clinical Implications for Patients With Prostate Cancer on Androgen Deprivation Therapy.
     J Urol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
207. ANDRIOLE GL , Bostwick D, Brawley OW, Gomella L, et al
     The Effect of Dutasteride on the Usefulness of Prostate Specific Antigen for the Diagnosis of High Grade and Clinically Relevant Prostate Cancer in Men With a Previous Negative Biopsy: Results From the REDUCE Study.
     J Urol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
208. WOLTERS T , Roobol MJ, Leeuwen PJ, Bergh RC, et al
     A Critical Analysis of the Tumor Volume Threshold for Clinically Insignificant Prostate Cancer Using a Data Set of a Randomized Screening Trial.
     J Urol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
209. BRASSELL SA , Rice KR, Parker PM, Chen Y, et al
     Prostate Cancer in Men 70 Years Old or Older, Indolent or Aggressive: Clinicopathological Analysis and Outcomes.
     J Urol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
210. LIANG Y , Ankerst DP, Ketchum NS, Ercole B, et al
     Prospective Evaluation of Operating Characteristics of Prostate Cancer Detection Biomarkers.
     J Urol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
211. NETTO GJ
     Tumor Volume Threshold of Insignificant Prostate Cancer-Was Dr. Stamey Right All Along?
     J Urol. 2010.
     PubMed     Text format     Related articles   
     
     
     
     
212. KOCH MO
     Should the patient with positive margins after radical prostatectomy receive adjuvant radiation?
     J Urol. 2010;184:1838-9.
     PubMed     Text format     Related articles   
     
     
     
     
213. JUANG HH , Lin YF, Chang PL, Tsui KH, et al
     Cardiac glycosides decrease prostate specific antigen expression by down-regulation of prostate derived Ets factor.
     J Urol. 2010;184:2158-64.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
214. RENZULLI JF 2ND , Del Tatto M, Dooner G, Aliotta J, et al
     Microvesicle induction of prostate specific gene expression in normal human bone marrow cells.
     J Urol. 2010;184:2165-71.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
215. AUBIN SM , Reid J, Sarno MJ, Blase A, et al
     PCA3 molecular urine test for predicting repeat prostate biopsy outcome in populations at risk: validation in the placebo arm of the dutasteride REDUCE trial.
     J Urol. 2010;184:1947-52.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
216. SWANSON SK
     Should the patient with positive margins after radical prostatectomy receive adjuvant radiation?
     J Urol. 2010;184:1837-8.
     PubMed     Text format     Related articles   
     
     
     
     
217. CHEN YB , Pierorazio PM, Epstein JI
     Initial atypical diagnosis with carcinoma on subsequent prostate needle biopsy: findings at radical prostatectomy.
     J Urol. 2010;184:1953-7.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
218. POULIOT F , Wu L
     Cardiac glycosides may affect prostate specific antigen levels.
     J Urol. 2010;184:1831-2.
     PubMed     Text format     Related articles   
     
     
     
     October 2010
219. HWANG JJ , Kim YS, Kim MJ, Kim DE, et al
     Histone Deacetylase Inhibitor Potentiates Anticancer Effect of Docetaxel via Modulation of Bcl-2 Family Proteins and Tubulin in Hormone Refractory Prostate Cancer Cells.
     J Urol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
220. PRICE DK , Chau CH, Till C, Goodman PJ, et al
     Androgen Receptor CAG Repeat Length and Association With Prostate Cancer Risk: Results From the Prostate Cancer Prevention Trial.
     J Urol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
221. SMITH MR , Klotz L, Persson BE, Olesen TK, et al
     Cardiovascular Safety of Degarelix: Results From a 12-Month, Comparative, Randomized, Open Label, Parallel Group Phase III Trial in Patients With Prostate Cancer.
     J Urol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
222. SKOLARUS TA , Miller DC, Zhang Y, Hollingsworth JM, et al
     The Delivery of Prostate Cancer Care in the United States: Implications for Delivery System Reform.
     J Urol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
223. STAFFORD RJ , Shetty A, Elliott AM, Klumpp SA, et al
     Magnetic resonance guided, focal laser induced interstitial thermal therapy in a canine prostate model.
     J Urol. 2010;184:1514-20.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
224. KLEIN T , Palisaar RJ, Holz A, Brock M, et al
     The impact of prostate biopsy and periprostatic nerve block on erectile and voiding function: a prospective study.
     J Urol. 2010;184:1447-52.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
225. DROLLER MJ
     Citizenship in our profession.
     J Urol. 2010;184:1248-50.
     PubMed     Text format     Related articles   
     
     
     
     
226. SALEM S , Chang SS, Clark PE, Davis R, et al
     Comparative analysis of whole mount processing and systematic sampling of radical prostatectomy specimens: pathological outcomes and risk of biochemical recurrence.
     J Urol. 2010;184:1334-40.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
227. BUDAUS L , Isbarn H, Eichelberg C, Lughezzani G, et al
     Biochemical recurrence after radical prostatectomy: multiplicative interaction between surgical margin status and pathological stage.
     J Urol. 2010;184:1341-6.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
228. ROBINSON BD , Epstein JI
     Intraductal carcinoma of the prostate without invasive carcinoma on needle biopsy: emphasis on radical prostatectomy findings.
     J Urol. 2010;184:1328-33.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     September 2010
229. TAKIZAWA I , Hara N, Nishiyama T, Isahaya E, et al
     Adrenocorticotropic Hormone is Involved in Regulation of Androgen Synthesis in Men Receiving Androgen Deprivation Therapy for Localized Prostate Cancer.
     J Urol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
230. YOON DK , Park HS, Park JY
     Re: Prostate Specific Antigen Decrease and Prostate Cancer Diagnosis: Antibiotic Versus Placebo Prospective Randomized Clinical Trial R. M. Stopiglia, U. Ferreira, M. M. Silva, W. E. Matheus, F. Denardi and L. O. ReisJ Urol 2010; 183: 940-945.
     J Urol. 2010.
     PubMed     Text format     Related articles   
     
     
     
     
231. JEONG IG , Kim JK, Cho KS, You D, et al
     Diffusion-Weighted Magnetic Resonance Imaging in Patients With Unilateral Prostate Cancer on Extended Prostate Biopsy: Predictive Accuracy of Laterality and Implications for Hemi-Ablative Therapy.
     J Urol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
232. CELHAY O , Yacoub M, Irani J, Dore B, et al
     Expression of Estrogen Related Proteins in Hormone Refractory Prostate Cancer: Association With Tumor Progression.
     J Urol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
233. ABRAHAM NE , Makarov DV, Laze J, Stefanovics E, et al
     Patient Centered Outcomes in Prostate Cancer Treatment: Predictors of Satisfaction Up to 2 Years After Open Radical Retropubic Prostatectomy.
     J Urol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
234. PORTEN SP , Richardson DA, Odisho AY, McAninch JW, et al
     Disproportionate Presentation of High Risk Prostate Cancer in a Safety Net Health System.
     J Urol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
235. LEE MC , Moussa AS, Yu C, Kattan MW, et al
     Multifocal High Grade Prostatic Intraepithelial Neoplasia is a Risk Factor for Subsequent Prostate Cancer.
     J Urol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
236. INGRAM DG , Kattan MW
     Risk Grouping Versus Risk Continuum in Patients With Clinically Localized Prostate Cancer: A Taxometric Test.
     J Urol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
237. LOBLAW A , Zhang L, Lam A, Nam R, et al
     Comparing Prostate Specific Antigen Triggers for Intervention in Men With Stable Prostate Cancer on Active Surveillance.
     J Urol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
238. NETO AS , Tobias-Machado M, Wroclawski ML, Fonseca FL, et al
     Her-2/neu expression in prostate adenocarcinoma: a systematic review and meta-analysis.
     J Urol. 2010;184:842-50.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     August 2010
239. OZCAN MF , Akbulut Z, Canda AE, Kilic M, et al
     Re: Validation of the Partin Nomogram for Prostate Cancer in a National Sample J. B. Yu, D. V. Makarov, R. Sharma, R. E. Peschel, A. W. Partin and C. P. GrossJ Urol 2010; 183: 105-111.
     J Urol. 2010.
     PubMed     Text format     Related articles   
     
     
     
     
240. SEE WA
     Re: Comparative Effectiveness of Prostate Cancer Surgical Treatments: A Population Based Analysis of Postoperative Outcomes W. T. Lowrance, E. B. Elkin, L. M. Jacks, D. S. Yee, T. L. Jang, V. P. Laudone, B. D. Guillonneau, P. T. Scardino and J. A. Eas
     J Urol. 2010.
     PubMed     Text format     Related articles   
     
     
     
     
241. HOLMSTROM B , Holmberg E, Egevad L, Adolfsson J, et al
     Outcome of Primary Versus Deferred Radical Prostatectomy in the National Prostate Cancer Register of Sweden Followup Study.
     J Urol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
242. TALANTOV D , Jatkoe TA, Bohm M, Zhang Y, et al
     Gene Based Prediction of Clinically Localized Prostate Cancer Progression After Radical Prostatectomy.
     J Urol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
243. SMITH MR , Morton RA, Barnette KG, Sieber PR, et al
     Toremifene to Reduce Fracture Risk in Men Receiving Androgen Deprivation Therapy for Prostate Cancer.
     J Urol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
244. MORGENTALER A , Morales A
     Should Hypogonadal Men With Prostate Cancer Receive Testosterone?
     J Urol. 2010.
     PubMed     Text format     Related articles   
     
     
     
     
245. GORE JL , Gollapudi K, Bergman J, Kwan L, et al
     Correlates of Bother Following Treatment for Clinically Localized Prostate Cancer.
     J Urol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
246. HAMANO T , Matsui H, Sekine Y, Ohtake N, et al
     Association of SNP rs1447295 and Microsatellite Marker DG8S737 With Familial Prostate Cancer and High Grade Disease.
     J Urol. 2010;184:738-742.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
247. MOROTE J , Del Amo J, Borque A, Ars E, et al
     Improved prediction of biochemical recurrence after radical prostatectomy by genetic polymorphisms.
     J Urol. 2010;184:506-11.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
248. GARZOTTO M
     Editorial comment.
     J Urol. 2010;184:500.
     PubMed     Text format     Related articles   
     
     
     
     
249. MURTOLA T
     Editorial comment.
     J Urol. 2010;184:500.
     PubMed     Text format     Related articles   
     
     
     
     July 2010
250. AYRES BE , Bott SR, Barber NJ, Langley SE, et al
     Re: A Multi-Institutional Evaluation of Active Surveillance for Low Risk Prostate Cancer S. E. Eggener, A. Mueller, R. K. Berglund, R. Ayyathurai, C. Soloway, M. S. Soloway, R. Abouassaly, E. A. Klein, S. J. Jones, C. Zappavigna, L. Goldenberg, P. T.
     J Urol. 2010.
     PubMed     Text format     Related articles   
     
     
     
     
251. MA Z , Tsuchiya N, Yuasa T, Huang M, et al
     Clinical Significance of Polymorphism and Expression of Chromogranin A and Endothelin-1 in Prostate Cancer.
     J Urol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
252. ALIBHAI SM , Duong-Hua M, Cheung AM, Sutradhar R, et al
     Fracture Types and Risk Factors in Men With Prostate Cancer on Androgen Deprivation Therapy: A Matched Cohort Study of 19,079 Men.
     J Urol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
253. TOLLEFSON MK , Blute ML, Rangel LJ, Karnes RJ, et al
     Lifelong Yearly Prostate Specific Antigen Surveillance is Not Necessary for Low Risk Prostate Cancer Treated With Radical Prostatectomy.
     J Urol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
254. CRAIG BM , Gilbert SM, Herndon JB, Vogel B, et al
     Participation of Older Patients With Prostate Cancer in Medicare Eligible Trials.
     J Urol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
255. GIOVACCHINI G , Picchio M, Briganti A, Cozzarini C, et al
     [(11)C]Choline Positron Emission Tomography/Computerized Tomography to Restage Prostate Cancer Cases With Biochemical Failure After Radical Prostatectomy and No Disease Evidence on Conventional Imaging.
     J Urol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
256. VICKERS AJ , Wolters T, Savage CJ, Cronin AM, et al
     Prostate Specific Antigen Velocity Does Not Aid Prostate Cancer Detection in Men With Prior Negative Biopsy.
     J Urol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
257. AIGNER F , Pallwein L, Junker D, Schafer G, et al
     Value of Real-Time Elastography Targeted Biopsy for Prostate Cancer Detection in Men With Prostate Specific Antigen 1.25 ng/ml or Greater and 4.00 ng/ml or Less.
     J Urol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
258. NEWTON MR , Phillips S, Chang SS, Clark PE, et al
     Smaller Prostate Size Predicts High Grade Prostate Cancer at Final Pathology.
     J Urol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
259. PAPATSORIS A , Bourdoumis A, Chrisofos M
     Re: Accuracy of PCA3 Measurement in Predicting Short-Term Biopsy Progression in an Active Surveillance Program J. J. Tosoian, S. Loeb, A. Kettermann, P. Landis, D. J. Elliot, J. I. Epstein, A. W. Partin, H. B. Carter and L. J. Sokoll J Urol 2010; 183:
     J Urol. 2010;184:396-7.
     PubMed     Text format     Related articles   
     
     
     
     
260. HELFAND BT , Blackwell RH, McVary KT
     Consequences of switching 5alpha-reductase inhibitors on prostate specific antigen velocity.
     J Urol. 2010;184:218-23.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
261. LOEB S , Makarov DV, Schaeffer EM, Humphreys EB, et al
     Prostate specific antigen at the initial diagnosis of metastasis to bone in patients after radical prostatectomy.
     J Urol. 2010;184:157-61.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
262. GOTTO GT , Yunis LH, Vora K, Eastham JA, et al
     Impact of prior prostate radiation on complications after radical prostatectomy.
     J Urol. 2010;184:136-42.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
263. VON BODMAN C , Godoy G, Chade DC, Cronin A, et al
     Predicting biochemical recurrence-free survival for patients with positive pelvic lymph nodes at radical prostatectomy.
     J Urol. 2010;184:143-8.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
264. BRIMO F , Schultz L, Epstein JI
     The value of mandatory second opinion pathology review of prostate needle biopsy interpretation before radical prostatectomy.
     J Urol. 2010;184:126-30.
     PubMed     Text format     Related articles    Abstract available
     
     
     

Thank you for your interest in scientific medicine.

Amedeo is a Flying Publisher website.    Design: